BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 28344213)

  • 21. The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.
    Gayarre J; Kamieniak MM; Cazorla-Jiménez A; Muñoz-Repeto I; Borrego S; García-Donas J; Hernando S; Robles-Díaz L; García-Bueno JM; Ramón Y Cajal T; Hernández-Agudo E; Heredia Soto V; Márquez-Rodas I; Echarri MJ; Lacambra-Calvet C; Sáez R; Cusidó M; Redondo A; Paz-Ares L; Hardisson D; Mendiola M; Palacios J; Benítez J; García MJ
    J Gynecol Oncol; 2016 Jan; 27(1):e7. PubMed ID: 26463438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TBL1XR1 predicts isolated tumor cells and micrometastasis in patients with TNM stage I/II colorectal cancer.
    Liu H; Liu Z; Li K; Li S; Song L; Gong Z; Shi W; Yang H; Xu Y; Ning S; Ismail S; Chen Y
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1570-1580. PubMed ID: 28127799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Gab1 Is Associated with Poor Prognosis of Patients with Epithelial Ovarian Cancer.
    Hu L; Liu R
    Tohoku J Exp Med; 2016 Jul; 239(3):177-84. PubMed ID: 27302321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.
    Yang S; Li H; Liu Y; Ning X; Meng F; Xiao M; Wang D; Lou G; Zhang Y
    Med Oncol; 2013 Mar; 30(1):324. PubMed ID: 23254963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
    Li T; Xue H; Guo Y; Guo K
    Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.
    Wang M; He Y; Shi L; Shi C
    Eur J Gynaecol Oncol; 2011; 32(2):171-7. PubMed ID: 21614907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
    Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
    Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
    Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
    Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma.
    Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X
    Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway.
    Zhou Q; Wang X; Yu Z; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
    Oncogene; 2017 Mar; 36(13):1873-1886. PubMed ID: 27694893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
    Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
    Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.
    Furlong F; Fitzpatrick P; O'Toole S; Phelan S; McGrogan B; Maguire A; O'Grady A; Gallagher M; Prencipe M; McGoldrick A; McGettigan P; Brennan D; Sheils O; Martin C; W Kay E; O'Leary J; McCann A
    J Pathol; 2012 Apr; 226(5):746-55. PubMed ID: 22069160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma.
    Jung SG; Kwon YD; Song JA; Back MJ; Lee SY; Lee C; Hwang YY; An HJ
    Cancer Sci; 2010 Sep; 101(9):1977-83. PubMed ID: 20624166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Over-expression of semaphorin4D, hypoxia-inducible factor-1α and vascular endothelial growth factor is related to poor prognosis in ovarian epithelial cancer.
    Chen Y; Zhang L; Pan Y; Ren X; Hao Q
    Int J Mol Sci; 2012 Oct; 13(10):13264-74. PubMed ID: 23202951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
    Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
    Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients.
    Zhang Y; Hua W; Niu LC; Li SM; Wang YM; Shang L; Zhang C; Li WN; Wang R; Chen BL; Xin XY; Zhang YQ; Wang J
    Tumour Biol; 2016 Jul; 37(7):9423-31. PubMed ID: 26781874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer.
    Wen N; Wang Y; Wen L; Zhao SH; Ai ZH; Wang Y; Wu B; Lu HX; Yang H; Liu WC; Li Y
    J Transl Med; 2014 May; 12():134. PubMed ID: 24885308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma.
    Yokoyama Y; Charnock-Jones DS; Licence D; Yanaihara A; Hastings JM; Holland CM; Emoto M; Umemoto M; Sakamoto T; Sato S; Mizunuma H; Smith SK
    Br J Cancer; 2003 Jan; 88(2):237-44. PubMed ID: 12610509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer.
    Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL
    Oncotarget; 2015 Sep; 6(29):28491-501. PubMed ID: 26143638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.